Key result
Targeting inflammation and redox dysregulation in ischemia/reperfusion injury shows potential for reducing infarct size.
This review emphasizes the need for a deeper understanding of redox dysregulation and inflammation in acute myocardial ischemia-reperfusion injury to develop effective therapies that reduce infarct size and prevent heart failure.
Answers are grounded in this paper and cite their sources.
Does not support antioxidant or anti-inflammatory therapies in acute myocardial IRI; leaves open mechanism-guided strategies for future trials.
BACKGROUND: The inflammatory response to acute myocardial ischaemia/ reperfusion injury (IRI) plays a critical role in determining myocardial infarct (MI) size, and subsequent post-MI left ventricular (LV) remodelling, making it a potential therapeutic target for improving clinical outcomes in patients presenting with an acute myocardial infarction (AMI). Recent experimental studies using advanced imaging and molecular techniques, have yielded new insights into the mechanisms through which reactive oxygen species (ROS) contribute to the inflammatory response induced by acute myocardial IRI - "adding fuel to the fire". The infiltration of inflammatory cells into the MI zone, leads to elevated myocardial concentrations of ROS, cytokine release, and activation of apoptotic and necrotic death pathways. Anti-oxidant and anti-inflammatory therapies have failed to protect the heart against acute myocardial IRI. This may be, in part, due to a lack of understanding of the time course, nature and mechanisms of the inflammation and redox dysregulation, which occur in the setting of acute myocardial IRI. CONCLUSION: In this article, we examine the inflammatory response and redox dysregulation induced by acute myocardial IRI, and highlight potential therapeutic options for targeting redox dysregulation, in order to attenuate the detrimental effects of the inflammatory response following an AMI, so as to reduce MI size and prevent heart failure.
No takes yet. Share an insight, caveat, or question.
Hernández‐Reséndiz et al. (2017) conducted a review in Acute myocardial ischaemia-reperfusion injury. The inflammatory response to acute myocardial ischemia/reperfusion injury, driven by redox dysregulation and reactive oxygen species, represents a potential therapeutic target for reducing infarct size.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: